Protein "melanoma inhibitory activity" (MIA) in the human choroidal melanoma SCID-mouse model.

被引：0
|
作者：
Schaller, UC
Mueller, AJ
Bosserhoff, AK
Kan-Mitchell, J
Freeman, WR
Folberg, R
Buettner, R
Kampik, A
机构：
[1] Univ Munich, Eye Dept, Munich, Germany
[2] Rhein Westfal TH Aachen, Inst Pathol, D-5100 Aachen, Germany
[3] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA
[5] Univ Illinois, Chicago, IL USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2001年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
599
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [31] MIA (melanoma inhibitory activity):: a potential serum marker for rheumatoid arthritis
    Müller-Ladner, U
    Bosserhoff, AK
    Dreher, K
    Hein, R
    Neidhart, M
    Gay, S
    Schölmerich, J
    Buettner, R
    Lang, B
    [J]. RHEUMATOLOGY, 1999, 38 (02) : 148 - 154
  • [32] Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
    Jamael El Fitori
    Jörg Kleeff
    Nathalia A Giese
    Ahmed Guweidhi
    Anja K Bosserhoff
    Markus W Büchler
    Helmut Friess
    [J]. Cancer Cell International, 5
  • [33] Melanoma inhibitory activity (MIA) acts as a mediator of oncogene-induced senescence in human melanocytes
    Schiffner, S.
    Bosserhoff, A.
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 2010, 89 : 3 - 3
  • [34] Secreted melanoma inhibitory activity (MIA) is a biomarker of chondrocyte anabolism.
    Vandooren, Bernard
    Cantaert, Tineke
    van Lierop, Marie-Jose
    Veys, Eric M.
    Bos, Ebo
    Tak, Paul P.
    Boots, Annemieke M.
    Baeten, Dominique
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S577 - S577
  • [35] RECEIVER OPERATING CHARACTERISTIC CURVE FOR THE MARKER "MELANOMA INHIBITORY ACTIVITY" (MIA) IN PATIENTS WITH METASTATIC UVEAL MELANOMA
    Klingenstein, Annemarie
    Haritoglou, Ingrid
    Schaumberger, M.
    Nentwich, M. M.
    Hein, R.
    Schaller, U. C.
    [J]. TUMOR BIOLOGY, 2010, 31 : S95 - S95
  • [36] Utility of Melanoma Inhibitory Activity (MIA) in malignant melanoma patients, comparison with S100B
    Auge, J. M.
    Molina, R.
    Domingo, J.
    Filella, X.
    Puig, S.
    [J]. TUMOR BIOLOGY, 2007, 28 : 89 - 89
  • [37] Therapeutic efficacy of Re-188 labeled alpha-MSH peptide in a human melanoma xenografted scid mouse model.
    Miao, Y
    Owen, NK
    Hoffman, TJ
    Quinn, TP
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 178P - 178P
  • [38] Cyclin-dependent kinase inhibitory protein express in human choroidal melanoma tumors
    Mouriaux, F
    Maurage, CA
    Labalette, P
    Sablonnière, B
    Malecaze, F
    Darbon, JM
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (10) : 2837 - 2843
  • [39] Effects of a novel metalloproteinase-inhibitor (AG3340) on subcutaneous and ocular tumors in the human choroidal melanoma scid mouse model
    Mueller, AJ
    Bartsch, D
    Shalinsky, D
    Appelt, K
    Folberg, R
    Freeman, WR
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S247 - S247
  • [40] Influence of local treatment or metastatic disease on melanoma inhibitory activity (MIA) serum levels in patients with uveal melanoma
    Schaller, UC
    Mueller, AJ
    Bosserhoff, AK
    Buettner, R
    Kampik, A
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U686 - U686
12345